Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development.

Luo G, Guenthner T, Gan LS, Humphreys WG.

Curr Drug Metab. 2004 Dec;5(6):483-505. Review.

PMID:
15578943
3.

Goldschlager allergy in a gold allergic patient.

Guenthner T, Stork CM, Cantor RM.

Vet Hum Toxicol. 1999 Aug;41(4):246.

PMID:
10434381
4.

Isolation of liver nuclei that retain functional trans-membrane transport.

Ho YF, Guenthner TM.

J Pharmacol Toxicol Methods. 1997 Nov;38(3):163-8.

PMID:
9523770
5.
6.

Purification of warfarin-sensitive vitamin K epoxide reductase.

Wallin R, Guenthner TM.

Methods Enzymol. 1997;282:395-408. No abstract available.

PMID:
9330304
7.

Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs.

Luo G, Guenthner TM.

Drug Metab Dispos. 1996 Sep;24(9):1020-7. Erratum in: Drug Metab Dispos 1997 Jan;25(1):131.

PMID:
8886614
8.

Compartmentation of glutathione: implications for the study of toxicity and disease.

Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH.

Toxicol Appl Pharmacol. 1996 Sep;140(1):1-12. Review.

PMID:
8806864
9.

Development of an in situ toxicity assay system using recombinant baculoviruses.

Grant DF, Greene JF, Pinot F, Borhan B, Moghaddam MF, Hammock BD, McCutchen B, Ohkawa H, Luo G, Guenthner TM.

Biochem Pharmacol. 1996 Feb 23;51(4):503-15.

PMID:
8619897
10.

Accuracy of video imaging in mandibular surgery.

Carter AC, Larson BE, Guenthner TA.

Int J Adult Orthodon Orthognath Surg. 1996;11(4):289-300.

PMID:
9456606
11.

Metabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.

Luo G, Guenthner TM.

J Pharmacol Exp Ther. 1995 Feb;272(2):588-96.

PMID:
7853172
12.
13.
15.

Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA.

Wheeler CW, Wrighton SA, Guenthner TM.

Biochem Pharmacol. 1992 Jul 7;44(1):183-7.

PMID:
1632834
16.

Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.

Luo G, Qato MK, Guenthner TM.

Drug Metab Dispos. 1992 May-Jun;20(3):440-5. Erratum in: Drug Metab Dispos Biol Fate Chem 1994 Mar-Apr;22(2):340.

PMID:
1521503
17.

An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.

Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK.

Biochem Pharmacol. 1992 Apr 15;43(8):1675-82.

PMID:
1575766
18.

Direct measurement of melphalan conjugation with glutathione: studies with human melanoma cells and mammalian liver.

Guenthner TM, Whalen R, Jevtović-Todorović V.

J Pharmacol Exp Ther. 1992 Mar;260(3):1331-6.

PMID:
1545395
19.

Sensitization of human melanoma cells to melphalan cytotoxicity by adriamycin and carmustine.

Jevtović-Todorović V, Guenthner TM.

J Cancer Res Clin Oncol. 1991;117(4):313-20. Erratum in: J Cancer Res Clin Oncol 2001 May;127(5):329. Jevtorić-Todorović, V [corrected to Jevtović-Todorović, V].

PMID:
2066351
20.

Cytochrome P-450-dependent metabolism of xenobiotics in human lung.

Wheeler CW, Guenthner TM.

J Biochem Toxicol. 1991 Fall;6(3):163-9. Review. No abstract available.

PMID:
1770500
21.

Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.

Wheeler CW, Park SS, Guenthner TM.

Mol Pharmacol. 1990 Nov;38(5):634-43.

PMID:
2233699
22.

Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites.

Hjelle JT, Guenthner TM, Bell K, Whalen R, Flouret G, Carone FA.

Toxicology. 1990 Mar 16;60(3):211-22.

PMID:
2315942
23.

Production of monospecific antiserum to a cytosolic epoxide hydrolase from human liver.

Qato MK, Reinmund SG, Guenthner TM.

Biochem Pharmacol. 1990 Jan 15;39(2):293-300.

PMID:
2302254
24.

Spectroscopic quantitation of cytochrome P-450 in human lung microsomes.

Wheeler CW, Guenthner TM.

J Biochem Toxicol. 1990 Winter;5(4):269-72.

PMID:
2096222
25.

Similarities between catalase and cytosolic epoxide hydrolase.

Guenthner TM, Qato M, Whalen R, Glomb S.

Drug Metab Rev. 1989;20(2-4):733-48.

PMID:
2806078
26.

Selective inhibition of cytosolic epoxide hydrolase activity in vitro by compounds that inhibit catalase.

Guenthner TM, Hjelle JT, Whalen R.

J Biochem Toxicol. 1989 Winter;4(4):241-9.

PMID:
2634095
27.

In vitro synthesis of fluorescein monoglucuronide.

Guenthner TM, Blair NP.

Pharmacology. 1988;37(5):341-8.

PMID:
3237763
28.

A case report and review of deciduous molar ankylosis.

Kellogg EM, Guenthner TA.

Northwest Dent. 1987 Nov-Dec;66(6):15-8. Review. No abstract available.

PMID:
3329339
29.

Immunochemical characterization of human lung epoxide hydrolases.

Guenthner TM, Karnezis TA.

J Biochem Toxicol. 1986 Dec;1(4):67-81.

PMID:
3271885
30.

Characterization of multiple epoxide hydrolase activities in mouse liver nuclear envelope.

Guenthner TM.

Biochem Pharmacol. 1986 Oct 1;35(19):3261-6.

PMID:
3768020
32.

Selective inhibition and selective induction of multiple microsomal epoxide hydrolases.

Guenthner TM.

Biochem Pharmacol. 1986 Mar 1;35(5):839-45.

PMID:
3954789
33.
34.

Multiple epoxide hydrolases in human lung.

Guenthner TM, Karnezis TA.

Drug Metab Dispos. 1986 Mar-Apr;14(2):208-13.

PMID:
2870896
35.

Vitamin K epoxide reductase activity in the metabolism of epoxides.

Liptay-Reuter I, Dose K, Guenthner T, Wörner W, Oesch F.

Biochem Pharmacol. 1985 Aug 1;34(15):2617-20.

PMID:
4015704
36.

The effect of Le Fort I maxillary impaction on nasal airway resistance.

Guenthner TA, Sather AH, Kern EB.

Am J Orthod. 1984 Apr;85(4):308-15.

PMID:
6585148
37.
38.

Existence of multiple forms of microsomal epoxide hydrolases with radically different substrate specificities.

Oesch F, Timms CW, Walker CH, Guenthner TM, Sparrow A, Watabe T, Wolf CR.

Carcinogenesis. 1984 Jan;5(1):7-9.

PMID:
6690087
39.
40.

Use of monoclonal and polyclonal antibodies as structural and topographical probes for hepatic epoxide hydrolase.

Wolf CR, Oesch F, Timms C, Guenthner T, Hartmann R, Maruhn M, Burger R.

FEBS Lett. 1983 Jul 4;157(2):271-6.

41.

Characterization of microsomal epoxide hydrolase in hyperplastic liver nodules of rats.

Oesch F, Vogel-Bindel U, Guenthner TM, Cameron R, Farber E.

Cancer Res. 1983 Jan;43(1):313-9. No abstract available.

42.
43.

Inactivation of a diol epoxide by dihydrodiol dehydrogenase but not by two epoxide hydrolases.

Glatt HR, Cooper CS, Grover PL, Sims P, Bentley P, Merdes M, Waechter F, Vogel K, Guenthner TM, Oesch F.

Science. 1982 Mar 19;215(4539):1507-9.

PMID:
7038877
44.
45.

Topology of epoxide hydrolase in the membrane of the endoplasmic reticulum.

Seidegård J, DePierre JW, Guenthner TM, Oesch F.

Acta Chem Scand B. 1982;36(8):555-7. No abstract available.

PMID:
7180330
46.

Rapid and sensitive enzyme-linked immunosorbent assay for the microsomal epoxide hydrolase.

Gill SS, Wie SI, Guenthner TM, Oesch F, Hammock BD.

Carcinogenesis. 1982;3(11):1307-10.

PMID:
6817936
47.

Cytosolic and microsomal epoxide hydrolases are immunologically distinguishable from each other in the rat and mouse.

Guenthner TM, Hammock BD, Vogel U, Oesch F.

J Biol Chem. 1981 Apr 10;256(7):3163-6.

48.

Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis.

Kuhlmann WD, Krischan R, Kunz W, Guenthner TM, Oesch F.

Biochem Biophys Res Commun. 1981 Jan 30;98(2):417-23. No abstract available.

PMID:
6111998
49.

Microsomal epoxide hydrolase.

Guenthner TM, Bentley P, Oesch F.

Methods Enzymol. 1981;77:344-9. No abstract available.

PMID:
7329313

Supplemental Content

Loading ...
Support Center